Candace Pert And Solomon Snyder

The Opioid Receptor Discovery and the Scientists Behind It

Candace Pert and Solomon Snyder are the names attached to one of the most important discoveries in neuroscience. In the early 1970s, they independently found evidence for specific opioid receptors in the brain, proving that drugs like morphine and heroin work by binding to defined protein targets rather than causing some vague, non-specific depression of nervous system activity. This finding changed how pharmacology and medicine approach pain, addiction, and drug development. Their story is not clean. Snyder's lab at Johns Hopkins had been investigating whether the brain contained specific binding sites for opiate drugs for several years before Pert, then a graduate student at Rockefeller University, produced her landmark paper. Both groups were using radioligand binding, a technique that uses a radioactive version of a drug molecule to map where it attaches in tissue. The method itself is straightforward in principle but finicky in practice. Snyder's team published their key findings first in 1972, showing that morphine and related compounds bound to a specific site in brain membranes. Pert's 1973 paper, which used a different radioactive tracer based on leucine-enkephalin and cocaine derivatives, independently confirmed the existence of the receptor and mapped its distribution across brain regions using quantitative autoradiography. She also showed that the binding was saturable and competitively reversible, two properties that define a true receptor.

What happened next is the part people remember. For a time, the two labs did not communicate directly. There was mild professional friction over priority and credit. Eventually they collaborated, and the science moved forward. The receptor they identified is now classified as the mu-opioid receptor, and the discovery opened the door to finding endogenous ligands like enkephalins, dynorphins, and endorphins. I have spent years working with receptor binding assays, and here is what nobody tells you about replicating this kind of work. The tissue you use matters more than most protocols admit. Snyder used rat brain homogenates, and the results held up because rat brain has high mu-receptor density in areas like the periaqueductal gray and the corpus striatum. If you switch to mouse or primate tissue without adjusting your detergent concentrations and incubation times, your specific-to-non-specific binding ratio drops sharply. I ran an experiment once using frozen rat brain from a different vendor and got essentially flat binding curves. The issue turned out to be repeated freeze-thaw cycles degrading the membrane proteins. Flash-freezing fresh tissue and keeping everything below minus eighty the whole time made the difference between noise and a clean Scatchard plot. Another detail that trips people up is the choice of assay buffer. Tris-HCl at pH 7.4 is standard, but the ionic strength and the presence of divalent cations change how tightly the ligand binds. Adding ten millimolar magnesium chloride typically improves signal-to-noise for mu-receptor binding by stabilizing the membrane environment. Skip it and you will waste hours wondering why your competition curves are shallow and inconsistent.

Pert's autoradiography work required a different set of considerations. She sliced brain tissue into thin sections, exposed them to photographic film with the radioactive ligand, and then quantified the grain density over specific nuclei. The resolution of this method means you can see receptor distribution at the level of individual brain structures, not just whole-hemisphere averages. That spatial detail was the part that made her data so convincing. Snyder's membrane-binding approach told you the receptor existed and how it behaved pharmacologically. Pert's imaging told you exactly where it lived. The broader scientific implication of their work is hard to overstate. Before the opioid receptor was identified, the mechanism of opiate action was understood mostly through behavioral and electrophysiological observations. The receptor proof gave pharmacology a concrete target. It allowed medicinal chemists to design molecules with measurable affinity, led to the isolation of endogenous opioid peptides, and eventually produced drugs like naltrexone for addiction treatment. It also established the template for finding receptors for dopamine, serotonin, GABA, and many other neurotransmitter systems. There is a limitation worth mentioning honestly. Radioligand binding tells you about affinity and density, but it does not tell you about downstream signaling. A compound can bind tightly to the mu-receptor and act as a partial agonist, an antagonist, or even an inverse agonist depending on the cellular context. Modern work uses biased agonism and functional assays like GTPgammaS binding or BRET sensors to get past the old binding-only picture. If you are trying to develop a new analgesic based solely on binding data, you will hit a wall. Binding affinity correlates imperfectly with efficacy, and some of the highest-affinity ligands produce surprisingly weak functional effects.

The cultural side of this story also deserves a clear look. The rivalry between Pert and Snyder was real but not destructive. Both were driven, both had strong egos, and both produced data that could not be ignored. The scientific process, as usual, corrected for the personal friction. The receptor was real whether either of them claimed priority first. That is the honest takeaway.

Practical Notes for Anyone Replicating This Work

If you are setting up an opioid receptor binding assay today, start with [3H]-DAMGO as your ligand for mu-selective work. It has a Kd in the low nanomolar range and gives clean saturation curves. Use membrane preparations from rat forebrain, homogenize in ice-cold Tris buffer, and centrifuge through a sucrose cushion to enrich the P2 fraction. Incubate for sixty minutes at twenty-three degrees Celsius, then filter through GF/B filters and wash three times with cold buffer. Count on a scintillation counter and subtract the nonspecific binding defined by ten micromolar unlabeled levorphanol. Pert's autoradiography can be approximated with [3H]-DHPG or [125I]-Deltorphin if you need delta-receptor detail alongside mu. The film exposure times run from several days to a week depending on ligand specific activity and section thickness. I typically use forty-micrometer free-floating sections mounted on gelatin-coated slides and expose them for five to seven days at four degrees Celsius with an intensifying screen. The results are reproducible if you keep your cryostat stable and your fixative consistent. The bottom line is that Candace Pert And Solomon Snyder established a method and a target that still underpin a large portion of modern neuroscience and pharmacology. Their contribution was not just the discovery of a receptor but the demonstration that a behavioral effect of a drug could be traced to a specific molecular interaction. That shift in thinking is what still matters most.